Kiora Pharmaceuticals, Inc. announced on February 9, 2022, Sarah Romano, the Chief Financial Officer, notified the Company that she will resign as Chief Financial Officer effective as of February 25, 2022 to pursue another opportunity.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5459 USD | +2.46% | -4.23% | +4.50% |
05-10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
03-25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.50% | 14.33M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- KPRX Stock
- News Kiora Pharmaceuticals, Inc.
- Kiora Pharmaceuticals, Inc. Announces Resignation of Sarah Romano as Chief Financial Officer, Effective February 25, 2022